These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 2828823

  • 1. The pathogenesis and prevention of diabetic neuropathy and nephropathy.
    Greene D.
    Metabolism; 1988 Feb; 37(2 Suppl 1):25-9. PubMed ID: 2828823
    [Abstract] [Full Text] [Related]

  • 2. Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol.
    Greene DA, Chakrabarti S, Lattimer SA, Sima AA.
    J Clin Invest; 1987 May; 79(5):1479-85. PubMed ID: 3033025
    [Abstract] [Full Text] [Related]

  • 3. Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats.
    Raccah D, Coste T, Cameron NE, Dufayet D, Vague P, Hohman TC.
    J Diabetes Complications; 1998 May; 12(3):154-62. PubMed ID: 9618071
    [Abstract] [Full Text] [Related]

  • 4. Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism.
    Greene DA, Lattimer-Greene S, Sima AA.
    Crit Rev Neurobiol; 1989 May; 5(2):143-219. PubMed ID: 2561904
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A sodium-pump defect in diabetic peripheral nerve corrected by sorbinil administration: relationship to myo-inositol metabolism and nerve conduction slowing.
    Greene DA.
    Metabolism; 1986 Apr; 35(4 Suppl 1):60-5. PubMed ID: 2421135
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy?
    Greene DA, Lattimer SA, Sima AA.
    Diabetes; 1988 Jun; 37(6):688-93. PubMed ID: 2838351
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nodal Na(+)-channel displacement is associated with nerve-conduction slowing in the chronically diabetic BB/W rat: prevention by aldose reductase inhibition.
    Cherian PV, Kamijo M, Angelides KJ, Sima AA.
    J Diabetes Complications; 1996 Jun; 10(4):192-200. PubMed ID: 8835918
    [Abstract] [Full Text] [Related]

  • 13. Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat.
    Sima AA, Lattimer SA, Yagihashi S, Greene DA.
    J Clin Invest; 1986 Feb; 77(2):474-84. PubMed ID: 3003160
    [Abstract] [Full Text] [Related]

  • 14. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy.
    Dyck PJ, Zimmerman BR, Vilen TH, Minnerath SR, Karnes JL, Yao JK, Poduslo JF.
    N Engl J Med; 1988 Sep 01; 319(9):542-8. PubMed ID: 3136330
    [Abstract] [Full Text] [Related]

  • 15. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications.
    Greene DA, Lattimer SA, Sima AA.
    N Engl J Med; 1987 Mar 05; 316(10):599-606. PubMed ID: 3027558
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.